secwatch.observer — SEC 8-K summary
======================================

Issuer:     NovoCure Ltd (NVCR)
CIK:        0001645113
Form:       8-K
Filed at:   2023-03-29T23:59:59+00:00
Accession:  0001645113-23-000032
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novocure elects Kristin Stafford to board of directors
------------------------------------------------------

- Kristin Stafford elected to Novocure board effective March 28, 2023.
- She is SVP, Chief Accounting Officer at Royalty Pharma plc.
- She receives option grant of $667,000 fair value, vesting over three years.
- She joins Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645113/000164511323000032/0001645113-23-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645113/000164511323000032/nvcr-20230328.htm
  HTML page:      https://secwatch.observer/filing/0001645113-23-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer